CD79A Gene Agammaglobulinemia type 3, autosomal recessive NGS Genetic Test
Short Name: CD79A Agammaglobulinemia Type 3 Test
Also known as: CD79A-related agammaglobulinemia, Autosomal recessive agammaglobulinemia type 3
CD79A Gene Agammaglobulinemia type 3, autosomal recessive NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 Weeks. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last reviewed: September 7, 2026
Overview
The purpose of this test is to identify mutations in the CD79A gene that cause Agammaglobulinemia Type 3, Autosomal Recessive. It aids in confirming diagnosis, guiding treatment decisions, and facilitating genetic counseling for affected individuals and families.
- Test Code
- 5566
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- 3 to 4 Weeks
- Fasting Required
- No
- Method
- Next-Generation Sequencing (NGS)
Sample Collection
Provide clinical history of the patient and undergo a genetic counseling session to draw a pedigree chart of family members affected with agammaglobulinemia.
Method: Venipuncture
Laboratory Analysis
Blood sample will be collected via venipuncture or using an FTA card for a drop of blood.
Report Delivery
Sample will be processed for DNA extraction and NGS analysis. Results will be available in 3 to 4 weeks.
Timeline: 3 to 4 Weeks
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this test is to identify mutations in the CD79A gene that cause Agammaglobulinemia Type 3, Autosomal Recessive. It aids in confirming diagnosis, guiding treatment decisions, and facilitating genetic counseling for affected individuals and families.
How to Prepare
- Ensure proper identification of the patient
- Use sterile collection tubes
- Label samples accurately with patient details
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"Early diagnosis through genetic testing is crucial for managing CD79A-related agammaglobulinemia, allowing timely intervention to prevent recurrent infections and improve quality of life."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Hemolyzed or clotted blood samples
- Insufficient sample volume
- Incorrectly labeled samples
Understanding Your Results
Pathogenic variant detected
Confirms diagnosis of CD79A Gene Agammaglobulinemia Type 3. Recommend immunologist consultation for management.
No pathogenic variant detected
Unlikely to have CD79A-related agammaglobulinemia. Consider other genetic or immunological tests if symptoms persist.
Variant of uncertain significance (VUS)
Further testing and clinical correlation recommended. Genetic counseling advised.
Consult a doctor if you or your child experience recurrent infections, chronic diarrhea, poor growth, or have a family history of immunodeficiency. Early diagnosis and treatment can prevent complications.
Limitations
- ⚠This test does not detect mutations in other genes associated with agammaglobulinemia
- ⚠Results may require confirmation with additional testing
- ⚠Genetic variants of uncertain significance (VUS) may be identified
Risks & Considerations
- ●Minor bruising or discomfort at the blood draw site
- ●Rare risk of infection
Interfering Factors
- ●Contaminated or degraded DNA samples
- ●Recent blood transfusions may affect results
Frequently Asked Questions
What is CD79A Gene Agammaglobulinemia Type 3?
What are the common symptoms of this condition?
How is the CD79A Gene Test performed?
What is the cost of the CD79A Gene Test at DNA Labs India?
Is home sample collection available for this test?
How long does it take to receive the test results?
What should I do before taking the test?
Is the CD79A Gene Test covered by insurance?
Can this test be performed on children?
What are the treatment options after a positive diagnosis?
How accurate is the NGS genetic test for CD79A mutations?
Who should consider getting this genetic test?
Related Tests
HLA - DR7 (DRB1*07) Test
₹6,000NFKB2 Gene Immunodeficiency common variable type 10 NGS Genetic Test
₹20,000LAMTOR2 Gene Immunodeficiency due to defect in MAPBP-interacting protein NGS Genetic Test
₹20,000AFF3 Gene Rheumatoid arthritis, susceptibility to NGS Genetic Test
₹20,000IL7R Gene Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type NGS Genetic Test
₹20,000TNF (RNA Detection) Qualitative Test
₹5,950Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.